Alar Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| State or Government | 1,766,000 | 2.64% |
| Institutions | 2,049,767 | 3.07% |
| VC/PE Firms | 10,410,000 | 15.6% |
| Individual Insiders | 14,484,412 | 21.7% |
| General Public | 38,089,821 | 57% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 17.2%.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 13,864,412 | NT$3.5b | 0% | no data | |||
| 6,888,000 | NT$1.7b | 0% | no data | |||
| 3,522,000 | NT$880.5m | 0% | 13.61% | |||
| 2,000,000 | NT$500.0m | 0% | 0.03% | |||
| 1,766,000 | NT$441.5m | 0% | no data | |||
| 620,000 | NT$155.0m | 0% | no data | |||
| 34,767 | NT$8.7m | 34.9% | no data | |||
| 15,000 | NT$3.8m | 0% | no data |